Comparative evaluation of Sensititre super( registered ) YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts
A recently developed microdilution method (Sensititre super( registered ) YeastOne) may represent a valid alternative to the National Committee for Clinical Laboratory Standards (NCCLS) method for routine testing. The Medical Mycology Committee of the Associazione Microbiologi Clinici Italiani (AMCL...
Gespeichert in:
Veröffentlicht in: | Mycoses 2004-10, Vol.47 (9-10), p.397-401 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 401 |
---|---|
container_issue | 9-10 |
container_start_page | 397 |
container_title | Mycoses |
container_volume | 47 |
creator | Lombardi, G Farina, C Andreoni, S Fazii, P Faggi, E Pini, G Manso, E Nanetti, A Mazzoni, A |
description | A recently developed microdilution method (Sensititre super( registered ) YeastOne) may represent a valid alternative to the National Committee for Clinical Laboratory Standards (NCCLS) method for routine testing. The Medical Mycology Committee of the Associazione Microbiologi Clinici Italiani (AMCLI) decided to evaluate its reproducibility and reliability compared with the NCCLS M27A protocol and the E-test. Nineteen strains each of Candida albicans and Ca. parapsilosis, isolated from systemic infections, were tested against amphotericin B, flucytosine, ketoconazole, itraconazole, and fluconazole. All the participating laboratories tested the YeastOne panels, while the E-test and the NCCLS method were performed by two laboratories each. Interlaboratory reproducibility showed a good correlation (from 95% for amphotericin B to 92.5% for flucytosine). The agreement between NCCLS and YeastOne ranged from 95 (ketoconazole and itraconazole) to 100% (amphotericin B and flucytosine), whereas the agreement between E-test and YeastOne ranged from 72.5 (fluconazole) to 100% (amphotericin B and flucytosine). The Sensititre super( registered ) YeastOne panels appear to be an excellent alternative to both the E-test and the NCCLS protocol for antifungal susceptibility testing.Original Abstract: Eine kuerzlich entwickelte Mikroverduennungsmethode (Sensititre super( registered ) YeastOne) kann eine Alternative zur NCCLS-Methode bei Routineuntersuchungen werden. Das Medizinische Mykologie Komitee der Associazione Microbiologi Clinici Italiani (AMCLI) hat entschieden, die neue Methode auf Reproduzierbarkeit und Verlaesslichkeit im Vergleich zum NCCLS M27A Protokoll und dem E-test zu ueberpruefen. Jeweils neunzehn Staemme von Candida albicans und C. parapsilosis, von systemischen Infektionen isoliert, wurden gegen Amphotericin B, Flucytosin, Ketoconazol, Itraconazol und Fluconazol getestet. Alle teilnehmenden Laboratorien wandten die YeastOne Panels an, waehrend der E-Test und die NCCLS-Methode bei jeweils zwei Laboratorien durchgefuehrt wurden. Die Reproduzierbarkeit zwischen den verschiedenen Laboratorien zeigte eine gute Korrelation (von 95% fuer Amphotericin B bis 92.5% fuer Flucytosin). Die Uebereinstimmung zwischen NCCLS und YeastOne reichte von 95% (Ketoconazol und Itraconazol) bis 100% (Amphotericin B und Flucytosin), wobei die Uebereinstimmung zwischen E-Test und YeastOne von 72.5% (Fluconazol) bis 100% (Amphotericin B und Flucytosin) reichte. Die Sensititre super( |
doi_str_mv | 10.1111/j.1439-0507.2004.01013.x |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_17842065</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17842065</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_178420653</originalsourceid><addsrcrecordid>eNqNjctOwzAQRS0EEuHxD7NCsIixk7QmSxQVdcFjUTasKtNOgivXDvYkon_C5-JIiDWzuXc0R2cYAym4THO747Iq61zMhOKFEBUXUsiSfx2x7O9wzDJRl2WuKqFO2VmMOyGkqot5xr4bv-910GRGBBy1HVL1DnwLK3TRkKGAEIcewzUE7EwkDLiFG3hDHenFIYyRA30gPDfN4wqeCnUPffDkN96CdltY5ISRoPUhrWTawXXaJmXcYE_m3VhDB5gQ47rp72ESxwt20mob8fI3z9nVw-K1WebJ_Tkker03yWCtduiHuJbqrirEfFb-G_wBFEFkMw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17842065</pqid></control><display><type>article</type><title>Comparative evaluation of Sensititre super( registered ) YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts</title><source>Access via Wiley Online Library</source><creator>Lombardi, G ; Farina, C ; Andreoni, S ; Fazii, P ; Faggi, E ; Pini, G ; Manso, E ; Nanetti, A ; Mazzoni, A</creator><creatorcontrib>Lombardi, G ; Farina, C ; Andreoni, S ; Fazii, P ; Faggi, E ; Pini, G ; Manso, E ; Nanetti, A ; Mazzoni, A</creatorcontrib><description>A recently developed microdilution method (Sensititre super( registered ) YeastOne) may represent a valid alternative to the National Committee for Clinical Laboratory Standards (NCCLS) method for routine testing. The Medical Mycology Committee of the Associazione Microbiologi Clinici Italiani (AMCLI) decided to evaluate its reproducibility and reliability compared with the NCCLS M27A protocol and the E-test. Nineteen strains each of Candida albicans and Ca. parapsilosis, isolated from systemic infections, were tested against amphotericin B, flucytosine, ketoconazole, itraconazole, and fluconazole. All the participating laboratories tested the YeastOne panels, while the E-test and the NCCLS method were performed by two laboratories each. Interlaboratory reproducibility showed a good correlation (from 95% for amphotericin B to 92.5% for flucytosine). The agreement between NCCLS and YeastOne ranged from 95 (ketoconazole and itraconazole) to 100% (amphotericin B and flucytosine), whereas the agreement between E-test and YeastOne ranged from 72.5 (fluconazole) to 100% (amphotericin B and flucytosine). The Sensititre super( registered ) YeastOne panels appear to be an excellent alternative to both the E-test and the NCCLS protocol for antifungal susceptibility testing.Original Abstract: Eine kuerzlich entwickelte Mikroverduennungsmethode (Sensititre super( registered ) YeastOne) kann eine Alternative zur NCCLS-Methode bei Routineuntersuchungen werden. Das Medizinische Mykologie Komitee der Associazione Microbiologi Clinici Italiani (AMCLI) hat entschieden, die neue Methode auf Reproduzierbarkeit und Verlaesslichkeit im Vergleich zum NCCLS M27A Protokoll und dem E-test zu ueberpruefen. Jeweils neunzehn Staemme von Candida albicans und C. parapsilosis, von systemischen Infektionen isoliert, wurden gegen Amphotericin B, Flucytosin, Ketoconazol, Itraconazol und Fluconazol getestet. Alle teilnehmenden Laboratorien wandten die YeastOne Panels an, waehrend der E-Test und die NCCLS-Methode bei jeweils zwei Laboratorien durchgefuehrt wurden. Die Reproduzierbarkeit zwischen den verschiedenen Laboratorien zeigte eine gute Korrelation (von 95% fuer Amphotericin B bis 92.5% fuer Flucytosin). Die Uebereinstimmung zwischen NCCLS und YeastOne reichte von 95% (Ketoconazol und Itraconazol) bis 100% (Amphotericin B und Flucytosin), wobei die Uebereinstimmung zwischen E-Test und YeastOne von 72.5% (Fluconazol) bis 100% (Amphotericin B und Flucytosin) reichte. Die Sensititre super( registered ) YeastOne Panels scheinen eine exzellente Alternative sowoh lzum E-Test als auch zum NCCLS-Protokoll fuer die Empfindlichkeitspruefung darzustellen.</description><identifier>ISSN: 0933-7407</identifier><identifier>EISSN: 1439-0507</identifier><identifier>DOI: 10.1111/j.1439-0507.2004.01013.x</identifier><language>eng</language><subject>Candida albicans ; Candida parapsilosis</subject><ispartof>Mycoses, 2004-10, Vol.47 (9-10), p.397-401</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Lombardi, G</creatorcontrib><creatorcontrib>Farina, C</creatorcontrib><creatorcontrib>Andreoni, S</creatorcontrib><creatorcontrib>Fazii, P</creatorcontrib><creatorcontrib>Faggi, E</creatorcontrib><creatorcontrib>Pini, G</creatorcontrib><creatorcontrib>Manso, E</creatorcontrib><creatorcontrib>Nanetti, A</creatorcontrib><creatorcontrib>Mazzoni, A</creatorcontrib><title>Comparative evaluation of Sensititre super( registered ) YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts</title><title>Mycoses</title><description>A recently developed microdilution method (Sensititre super( registered ) YeastOne) may represent a valid alternative to the National Committee for Clinical Laboratory Standards (NCCLS) method for routine testing. The Medical Mycology Committee of the Associazione Microbiologi Clinici Italiani (AMCLI) decided to evaluate its reproducibility and reliability compared with the NCCLS M27A protocol and the E-test. Nineteen strains each of Candida albicans and Ca. parapsilosis, isolated from systemic infections, were tested against amphotericin B, flucytosine, ketoconazole, itraconazole, and fluconazole. All the participating laboratories tested the YeastOne panels, while the E-test and the NCCLS method were performed by two laboratories each. Interlaboratory reproducibility showed a good correlation (from 95% for amphotericin B to 92.5% for flucytosine). The agreement between NCCLS and YeastOne ranged from 95 (ketoconazole and itraconazole) to 100% (amphotericin B and flucytosine), whereas the agreement between E-test and YeastOne ranged from 72.5 (fluconazole) to 100% (amphotericin B and flucytosine). The Sensititre super( registered ) YeastOne panels appear to be an excellent alternative to both the E-test and the NCCLS protocol for antifungal susceptibility testing.Original Abstract: Eine kuerzlich entwickelte Mikroverduennungsmethode (Sensititre super( registered ) YeastOne) kann eine Alternative zur NCCLS-Methode bei Routineuntersuchungen werden. Das Medizinische Mykologie Komitee der Associazione Microbiologi Clinici Italiani (AMCLI) hat entschieden, die neue Methode auf Reproduzierbarkeit und Verlaesslichkeit im Vergleich zum NCCLS M27A Protokoll und dem E-test zu ueberpruefen. Jeweils neunzehn Staemme von Candida albicans und C. parapsilosis, von systemischen Infektionen isoliert, wurden gegen Amphotericin B, Flucytosin, Ketoconazol, Itraconazol und Fluconazol getestet. Alle teilnehmenden Laboratorien wandten die YeastOne Panels an, waehrend der E-Test und die NCCLS-Methode bei jeweils zwei Laboratorien durchgefuehrt wurden. Die Reproduzierbarkeit zwischen den verschiedenen Laboratorien zeigte eine gute Korrelation (von 95% fuer Amphotericin B bis 92.5% fuer Flucytosin). Die Uebereinstimmung zwischen NCCLS und YeastOne reichte von 95% (Ketoconazol und Itraconazol) bis 100% (Amphotericin B und Flucytosin), wobei die Uebereinstimmung zwischen E-Test und YeastOne von 72.5% (Fluconazol) bis 100% (Amphotericin B und Flucytosin) reichte. Die Sensititre super( registered ) YeastOne Panels scheinen eine exzellente Alternative sowoh lzum E-Test als auch zum NCCLS-Protokoll fuer die Empfindlichkeitspruefung darzustellen.</description><subject>Candida albicans</subject><subject>Candida parapsilosis</subject><issn>0933-7407</issn><issn>1439-0507</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqNjctOwzAQRS0EEuHxD7NCsIixk7QmSxQVdcFjUTasKtNOgivXDvYkon_C5-JIiDWzuXc0R2cYAym4THO747Iq61zMhOKFEBUXUsiSfx2x7O9wzDJRl2WuKqFO2VmMOyGkqot5xr4bv-910GRGBBy1HVL1DnwLK3TRkKGAEIcewzUE7EwkDLiFG3hDHenFIYyRA30gPDfN4wqeCnUPffDkN96CdltY5ISRoPUhrWTawXXaJmXcYE_m3VhDB5gQ47rp72ESxwt20mob8fI3z9nVw-K1WebJ_Tkker03yWCtduiHuJbqrirEfFb-G_wBFEFkMw</recordid><startdate>20041001</startdate><enddate>20041001</enddate><creator>Lombardi, G</creator><creator>Farina, C</creator><creator>Andreoni, S</creator><creator>Fazii, P</creator><creator>Faggi, E</creator><creator>Pini, G</creator><creator>Manso, E</creator><creator>Nanetti, A</creator><creator>Mazzoni, A</creator><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope></search><sort><creationdate>20041001</creationdate><title>Comparative evaluation of Sensititre super( registered ) YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts</title><author>Lombardi, G ; Farina, C ; Andreoni, S ; Fazii, P ; Faggi, E ; Pini, G ; Manso, E ; Nanetti, A ; Mazzoni, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_178420653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Candida albicans</topic><topic>Candida parapsilosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lombardi, G</creatorcontrib><creatorcontrib>Farina, C</creatorcontrib><creatorcontrib>Andreoni, S</creatorcontrib><creatorcontrib>Fazii, P</creatorcontrib><creatorcontrib>Faggi, E</creatorcontrib><creatorcontrib>Pini, G</creatorcontrib><creatorcontrib>Manso, E</creatorcontrib><creatorcontrib>Nanetti, A</creatorcontrib><creatorcontrib>Mazzoni, A</creatorcontrib><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Mycoses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lombardi, G</au><au>Farina, C</au><au>Andreoni, S</au><au>Fazii, P</au><au>Faggi, E</au><au>Pini, G</au><au>Manso, E</au><au>Nanetti, A</au><au>Mazzoni, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative evaluation of Sensititre super( registered ) YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts</atitle><jtitle>Mycoses</jtitle><date>2004-10-01</date><risdate>2004</risdate><volume>47</volume><issue>9-10</issue><spage>397</spage><epage>401</epage><pages>397-401</pages><issn>0933-7407</issn><eissn>1439-0507</eissn><abstract>A recently developed microdilution method (Sensititre super( registered ) YeastOne) may represent a valid alternative to the National Committee for Clinical Laboratory Standards (NCCLS) method for routine testing. The Medical Mycology Committee of the Associazione Microbiologi Clinici Italiani (AMCLI) decided to evaluate its reproducibility and reliability compared with the NCCLS M27A protocol and the E-test. Nineteen strains each of Candida albicans and Ca. parapsilosis, isolated from systemic infections, were tested against amphotericin B, flucytosine, ketoconazole, itraconazole, and fluconazole. All the participating laboratories tested the YeastOne panels, while the E-test and the NCCLS method were performed by two laboratories each. Interlaboratory reproducibility showed a good correlation (from 95% for amphotericin B to 92.5% for flucytosine). The agreement between NCCLS and YeastOne ranged from 95 (ketoconazole and itraconazole) to 100% (amphotericin B and flucytosine), whereas the agreement between E-test and YeastOne ranged from 72.5 (fluconazole) to 100% (amphotericin B and flucytosine). The Sensititre super( registered ) YeastOne panels appear to be an excellent alternative to both the E-test and the NCCLS protocol for antifungal susceptibility testing.Original Abstract: Eine kuerzlich entwickelte Mikroverduennungsmethode (Sensititre super( registered ) YeastOne) kann eine Alternative zur NCCLS-Methode bei Routineuntersuchungen werden. Das Medizinische Mykologie Komitee der Associazione Microbiologi Clinici Italiani (AMCLI) hat entschieden, die neue Methode auf Reproduzierbarkeit und Verlaesslichkeit im Vergleich zum NCCLS M27A Protokoll und dem E-test zu ueberpruefen. Jeweils neunzehn Staemme von Candida albicans und C. parapsilosis, von systemischen Infektionen isoliert, wurden gegen Amphotericin B, Flucytosin, Ketoconazol, Itraconazol und Fluconazol getestet. Alle teilnehmenden Laboratorien wandten die YeastOne Panels an, waehrend der E-Test und die NCCLS-Methode bei jeweils zwei Laboratorien durchgefuehrt wurden. Die Reproduzierbarkeit zwischen den verschiedenen Laboratorien zeigte eine gute Korrelation (von 95% fuer Amphotericin B bis 92.5% fuer Flucytosin). Die Uebereinstimmung zwischen NCCLS und YeastOne reichte von 95% (Ketoconazol und Itraconazol) bis 100% (Amphotericin B und Flucytosin), wobei die Uebereinstimmung zwischen E-Test und YeastOne von 72.5% (Fluconazol) bis 100% (Amphotericin B und Flucytosin) reichte. Die Sensititre super( registered ) YeastOne Panels scheinen eine exzellente Alternative sowoh lzum E-Test als auch zum NCCLS-Protokoll fuer die Empfindlichkeitspruefung darzustellen.</abstract><doi>10.1111/j.1439-0507.2004.01013.x</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0933-7407 |
ispartof | Mycoses, 2004-10, Vol.47 (9-10), p.397-401 |
issn | 0933-7407 1439-0507 |
language | eng |
recordid | cdi_proquest_miscellaneous_17842065 |
source | Access via Wiley Online Library |
subjects | Candida albicans Candida parapsilosis |
title | Comparative evaluation of Sensititre super( registered ) YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T19%3A26%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20evaluation%20of%20Sensititre%20super(%20registered%20)%20YeastOne%20vs.%20the%20NCCLS%20M27A%20protocol%20and%20E-test%20for%20antifungal%20susceptibility%20testing%20of%20yeasts&rft.jtitle=Mycoses&rft.au=Lombardi,%20G&rft.date=2004-10-01&rft.volume=47&rft.issue=9-10&rft.spage=397&rft.epage=401&rft.pages=397-401&rft.issn=0933-7407&rft.eissn=1439-0507&rft_id=info:doi/10.1111/j.1439-0507.2004.01013.x&rft_dat=%3Cproquest%3E17842065%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17842065&rft_id=info:pmid/&rfr_iscdi=true |